Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Locally advanced undifferentiated small round cell sarcoma of the lung with novel SDCCAG8-AKT3 fusion and type II tumor immunity in the microenvironment: a rare case report. | Transl Lung Cancer Res | 2022 | 36090644 | PubTator, text mining | PubMed |
| The in vivo Interaction Landscape of Histones H3.1 and H3.3. | Mol Cell Proteomics | 2022 | 36089195 | PubTator, text mining | PubMed |
| A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges. | Cancers (Basel) | 2022 | 36077703 | PubTator, text mining | PubMed |
| Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells. | Cancers (Basel) | 2022 | 36077669 | PubTator, text mining | PubMed |
| Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes. | Cancers (Basel) | 2022 | 36077644 | PubTator, text mining | PubMed |
| Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. | Cancers (Basel) | 2022 | 36077629 | PubTator, text mining | PubMed |
| A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. | Leuk Lymphoma | 2022 | 36075047 | PubTator, text mining | PubMed |
| Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCO. | Leukemia | 2022 | 36071100 | PubTator, text mining | PubMed |
| Mutations in BCOR, a co-repressor of CRX/OTX2, are associated with early-onset retinal degeneration. | Sci Adv | 2022 | 36070393 | PubTator, text mining | PubMed |
| Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors. | NPJ Precis Oncol | 2022 | 36068285 | PubTator, text mining | PubMed |
| Integrated driver mutations profile of chinese gastrointestinal-natural killer/T-cell lymphoma. | Front Oncol | 2022 | 36059700 | PubTator, text mining | PubMed |
| DNA- and RNA-Binding Proteins Linked Transcriptional Control and Alternative Splicing Together in a Two-Layer Regulatory Network System of Chronic Myeloid Leukemia. | Front Mol Biosci | 2022 | 36052164 | PubTator, text mining | PubMed |
| NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring. | EJHaem | 2022 | 36051025 | PubTator, text mining | PubMed |
| Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents. | Front Pediatr | 2022 | 36046479 | PubTator, text mining | PubMed |
| Advances in molecular characterization of myeloid proliferations associated with Down syndrome. | Front Genet | 2022 | 36035173 | PubTator, text mining | PubMed |
| Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. | Front Immunol | 2022 | 36032081 | PubTator, text mining | PubMed |
| Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm. | Life (Basel) | 2022 | 36013314 | PubTator, text mining | PubMed |
| Brain Tumor Characterization Using Radiogenomics in Artificial Intelligence Framework. | Cancers (Basel) | 2022 | 36011048 | PubTator, text mining | PubMed |
| Molecular Threat of Splicing Factor Mutations to Myeloid Malignancies and Potential Therapeutic Modulations. | Biomedicines | 2022 | 36009519 | PubTator, text mining | PubMed |
| Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling. | Nat Commun | 2022 | 35987950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=48